Skip to main content
U.S. flag

An official website of the United States government

Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8

Bibliographic

Year of Publication:
2013
Contact PI Name:
Merce Pallas
Contact PI Affiliation:
Unitat de Farmacologia i Farmacognòsia Facultat de Farmàcia Universitat de Barcelona, Barcelona, Spain
Co-Authors:
David Porquet, Gemma Casadesús, Sergi Bayod, Alberto Vicente, Anna M. Canudas, Jordi Vilaplana, Carme Pelegrí, Coral Sanfeliu, Antoni Camins, Jaume del Valle
Primary Reference (PubMED ID):
Funding Source:
Spanish Ministry of Education and Science
Generalitat de Catalunya
Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo
Fundacion MAPFRE
Study Goal and Principal Findings:

This study investigated effects of resveratrol on neuroprotection, longevity, cognitive impairment, and neuropathology in SAMP8 mice. Resveratrol, a naturally occurring polyphenol mainly found in grapes and red wine, has been reported as a caloric restriction (CR) mimetic with potential anti-aging and antidiabetogenic properties. The most widely accepted mechanistic hypothesis is that resveratrol’s effects, in the same way as CR, are driven through Sirtuin 1 (SIRT1) regulation. It is widely accepted that resveratrol benefits are mediated through AMPK activation. Thus, resveratrol leads to increases in the NAD-to-NADH cell ratio, which results in activation of AMPK in vivo, initiating a signaling process that regulates insulin sensitivity and recruits mediators of oxidative metabolism and mitochondrial biogenesis. Several in vitro and in vivo studies also support the hypothesis that resveratrol may be a powerful agent in preventing age-associated neurodegeneration, such as lowering Aβ levels and improving cognitive deficits. This study used age-accelerated mice (SAMP8) that has age-related neuropathological changes like Aβ aggregation and tau hyperphosphorylation. Results show that resveratrol increased mean life expectancy and maximal life span, activates AMPK pathways and pro-survival routes such as SIRT1, reduces cognitive impairment,decreases amyloid burden, and reduces tau hyperphosphorylation.

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Dietary Interventions & Supplements
Therapeutic Agent:
Resveratrol
Therapeutic Target:
Multi Target

Animal Model

Model Information:
Species:
Mouse
Model Type:
Accelerated Aging
Strain/Genetic Background:
Not Reported
Species:
Mouse
Model Type:
Accelerated Aging Resistant
Strain/Genetic Background:
Not Reported

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Biomarkers
Dose
Formulation
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest

Outcomes

Outcome Measured
Outcome Parameters
Behavioral
Novel Object Recognition Test (NORT)
Biochemical
Sirtuins
AMP-Activated Protein Kinase (AMPK)
phospho-AMP-Activated Protein Kinase (phospho-AMPK)
p53 Acetylation
Brain-beta Amyloid Peptide 40
Brain-beta Amyloid Peptide 42
A Disintegrin and Metalloproteinase Domain 10 (ADAM10)
beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)
phospho-Tau
Cyclin-Dependent Kinase 5 (CDK5)
p25/p35/Cyclin-Dependent Kinase 5 Regulatory Subunit 1 (CDK5R1)
GSK3 beta/phospho-GSK3 beta
CDC2/phospho-CDC2
JNK/phospho-JNK
Immunochemistry
Brain-beta Amyloid Deposits
Toxicology
Survival
Mortality